I suspect that later, when they have more presence in the public and expert view, they will open up new payment options to increase visibility of their reports, but only after they have employed significantly more researchers and run them through rigorous epistemic ethics training. Otherwise, there's little stopping a Big Pharma company from hiring Metamed for a $3,000 report, and then posting a biased summary of the report on their news page, along with an "APPROVED BY METAMED" sticker. Even worse if Metamed considers the "approval sticker" to be useful to spreading awareness of evidence-based medicine. The potential for corruption is just too high.